Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Quick Stats
Jan 30, 202648.8
AI Score
HOLD0.46
Volume Ratio
Mar 12, 2026
Next Earnings
13
+ve Days (30d)
17
-ve Days (30d)
CLLS Stock Summary
Last updated Jan 30, 2026
CLLS is currently trading at $3.79, positioned above its 200-day moving average of $2.98, indicating a long-term uptrend. The stock has a 52-week range of $1.1 to $5.4796.
Technical Analysis: The 50-day moving average stands at $4.53, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 37.339, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.096, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CLLS at 48.8/100 with a HOLD recommendation.
CLLS (Cellectis S.A. American Depositary Shares) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 37.339 |
| CMF (20) | -0.096 |
| ROC (10) | -7.222 |
| ADX (14) | 14.238 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.127 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -98.601 |
| MFI (14) | 17.437 |
CLLS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CLLS Price vs Max Options Open Interest
CLLS Max Change In Options Open Interest
CLLS Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CLLS Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CLLS Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CLLS Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Cellectis S.A. American Depositary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
CLLS Moving Averages Analysis
Cellectis S.A. American Depositary Shares has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
CLLS (Cellectis S.A. American Depositary Shares) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 4.13 |
| 20 | 4.27 |
| 30 | 4.39 |
| 50 | 4.53 |
| 100 | 4.03 |
| 200 | 2.98 |
CLLS Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 396.8 million |
| Earnings/Share ($) | -0.33 |
| Net Proft Margin (%) | -0.4283 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.47 |
| EPS Estimate Next Year ($) | -0.62 |
| WallStreet Target Price ($) | 7 |
| Most Recent Quarter |